Affymetrix Stock Slides on News of Defective Mouse Arrays: Analysts Not Worried | GenomeWeb

NEW YORK, March 7 – After Affymetrix disclosed that its U74 Mouse arrays contained defective sequences, the microarray maker’s shares slid nearly 11 percent Wednesday by midday.

The company’s shares were down $5 15/16, at 50 1/16 in early-afternoon trading on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.